The IL6(-174G/C) polymorphism is a prognostic factor for survival after treatment initiation in Waldenstrom macroglobulinemia patients aged 65 years or less

Haematologica. 2008 Jul;93(7):1109-11. doi: 10.3324/haematol.12530. Epub 2008 May 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Female
  • Gene Expression Regulation*
  • Humans
  • Interleukin-6 / genetics*
  • Interleukin-6 / physiology
  • Male
  • Middle Aged
  • Models, Biological
  • Polymorphism, Genetic*
  • Prognosis
  • Treatment Outcome
  • Waldenstrom Macroglobulinemia / genetics*
  • Waldenstrom Macroglobulinemia / mortality

Substances

  • Interleukin-6